FODMAP Snap vs Aidy for Crohn's: Food Scan or Full Record?
By the Aidy Editorial Team
First Published May 2, 2026Last Updated Aug 19, 2026
FODMAP Snap's site focuses on meal analysis; Aidy connects food to Crohn's care. FODMAP Snap claims meal scans across seven FODMAP groups. Aidy connects food to symptoms, medication, biologic schedules, modified HBI trends, and reports.
Quick answer: For most people with Crohn's, choose Aidy for a free primary record with treatment context, modified HBI trends, and reports. FODMAP Snap is the genuine exception when a clinician-guided task benefits from its advertised meal scans and FODMAP estimates.
| Decision factor | Aidy | FODMAP Snap (public claims) |
|---|---|---|
| Best for | Complete Crohn's record | Claims FODMAP analysis |
| Daily IBD record | Food, stool, symptoms, treatment | Claims meals, symptoms, stress, mood |
| Treatment tools | Medicines and biologics | Claims no comparable workflow |
| Reports and insights | Modified HBI and reports | Claims estimates and Pro PDF |
| Access and cost | Free | Claims limited free scans and Pro |
| Overall pick | Aidy | FODMAP-question exception |
Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.
FODMAP Snap Is a Capable Scanner and Diary
A current FODMAP Snap review should credit how much the app can capture. Its official site describes photo, text, voice, and barcode meal entry, estimates for seven FODMAP categories, portion guidance, recipes, and tracking for symptoms, stress, mood, and menstrual cycles. The Apple listing also documents urgency logging and a downloadable PDF report for Pro users. Its store listings show availability on iPhone, iPad, and Android, giving it a platform advantage over Aidy's current iPhone listing.
Its public materials frame the product primarily around IBS and SIBO, with inflammatory bowel disease outside its stated scope. Its terms limit free accounts to three meal scans per day, with unlimited analysis through an automatically renewing Pro subscription. For someone testing a narrow meal hypothesis, this Crohn's FODMAP scanner offers a quick and approachable starting point.
AI Estimates Are Not Laboratory FODMAP Measurements
Convenience creates an important limitation. FODMAP Snap's terms acknowledge that AI output may contain errors and inaccuracies. Monash University explains that scanners based on ingredient lists provide estimates and can be less accurate than laboratory testing because processing methods and ingredient choices change FODMAP levels. Its barcode-scanner explanation is relevant to photo and text estimates too: a polished result should not be treated as a measured food concentration.
Low-FODMAP eating can still address a specific symptom question. A randomized trial in quiescent IBD found better relief of persistent gut symptoms after four weeks, without a difference in inflammatory markers. A systematic review and meta-analysis likewise found improvement in several symptoms, while noting limited evidence quality. A 2026 Rome and IOIBD consensus places short-term low-FODMAP therapy in the context of IBS-like symptoms after active inflammation and structural problems have been excluded.
Aidy Preserves Crohn's Disease and Treatment Context
A food scan app for IBD cannot establish whether symptoms reflect inflammation. NIDDK describes Crohn's diagnosis as a clinician-led process that may involve blood tests, stool tests, endoscopy, imaging, and biopsy. NIDDK also says a food diary may help identify foods associated with symptoms, while researchers have not identified specific foods that cause or worsen Crohn's symptoms. Its diet guidance stresses individualized nutrition and clinician involvement.
Aidy records meals, Bristol stool form, symptoms, blood, medication adherence, and common biologic schedules. It also calculates a modified HBI and prepares clinician-facing reports. Research supports patient-entered HBI as useful structured context, though an HBI does not replace objective assessment of inflammation. A 2024 validation study found strong agreement between patient and clinician HBI scores, and the AGA Crohn's biomarker guideline recommends combining symptoms with biomarkers in several monitoring situations.
Price and Privacy Need a Close Read
The FODMAP Snap Pro price is unclear. Apple lists five purchases without durations, while the terms describe an auto-renewing subscription. Confirm checkout terms. The terms say free users receive three scans daily.
Privacy disclosures also differ by source. FODMAP Snap's privacy policy says meal photos are processed through OpenAI's GPT-4 Vision API and identifies Firebase, RevenueCat, and Expo as service providers. It says users can request export or deletion. Google Play says data cannot be deleted, while Apple's label says identifiers may be used to track users across apps and websites. These conflicts deserve review before uploading meal and symptom data.
Aidy is free and has no paid patient subscriptions. Its full Crohn's tracking workflow is available without a patient subscription.
Which App Fits the Primary Crohn's Record?
FODMAP Snap is strongest when speed, Android access, recipes, or estimated FODMAP exposure is the immediate priority. Its developer claims urgency logs and a PDF, while its terms describe capped free scans and potentially inaccurate AI results. The listing leaves Pro durations unclear, and public materials center IBS and SIBO.
Aidy is the better FODMAP Snap alternative for an ongoing Crohn's record. Meals sit beside blood, stool, symptoms, adherence, biologic timing, modified HBI trends, and reports. FODMAP Snap can complement it during a supervised food investigation. The choice is focused food estimation versus longitudinal Crohn's tracking.
That division keeps the recommendation honest, focused, and specific to the task.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.